Two leading medical journals announced on Thursday that they
would begin publishing analyses that take advantage of the growing
availability of unreported study data to rebut the conclusions
presented in previous research findings.

The journals, BMJ and PLoS Medicine, made the
commitment along with a small group of researchers who said they
already have collected some 178,000 pages of companies' previously
confidential research documents related to published